JEROME P. GRISKO - 29 Nov 2022 Form 4 Insider Report for CBIZ, Inc. (CBZ)

Role
CEO & President, Director
Signature
Michael W. Gleespen, attorney-in-fact for Jerome P. Grisko, Jr.
Issuer symbol
CBZ
Transactions as of
29 Nov 2022
Transactions value $
-$1,073,276
Form type
4
Filing time
01 Dec 2022, 15:26:58 UTC
Previous filing
04 Nov 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBZ Common Stock Options Exercise $188,512 +12,123 +36% $15.55 45,409 29 Nov 2022 Direct
transaction CBZ Common Stock Tax liability -$375,371 -7,700 -17% $48.75 37,709 29 Nov 2022 Direct F1
transaction CBZ Common Stock Options Exercise $883,753 +56,833 +151% $15.55 94,542 30 Nov 2022 Direct
transaction CBZ Common Stock Tax liability -$1,770,169 -36,015 -38% $49.15 58,527 30 Nov 2022 Direct F2
holding CBZ Common Stock 302,000 29 Nov 2022 By spousal trust
holding CBZ Common Stock 473,747 29 Nov 2022 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBZ Employee Stock Option Options Exercise $0 -12,123 -13% $0 77,877 29 Nov 2022 Common Stock 12,123 $15.55 Direct F3
transaction CBZ Employee Stock Option Options Exercise $0 -56,833 -73% $0 21,044 30 Nov 2022 Common Stock 56,833 $15.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Weighted average sale price of price range between $48.53 and $48.87. Will provide upon request number of shares sold at each separate price.
F2 Weighted average sale price of price range between $48.20 and $49.66. Will provide upon request number of shares sold at each separate price.
F3 Consists of Options granted 05/10/2017 vesting in 25% increments each year beginning 05/10/2018 and expiring on 05/10/2023.